Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 7, 2019; 25(33): 4850-4869
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4850
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4850
Study | Pt numbers (n) | Average distance from Anal Verge (cm) | Positive margins | Local recurrence | Average length of follow-up |
Atallah et al[70], 2010 | 6 | 9.3 | 0 | N/A | N/A |
Albert et al[73], 2013 | 50 | 8.1 | 6% | 2 (4%) | N/A |
Keller et al[74], 2016 | 75 17 (malignant) 58 (benign) | 10 | 5 | ||
Garcia-Florez et al[106], 2017 | 32 | 5.6 | 1 | 10.3% | 26 mo |
Van den Eynde et al[105], 2019 | 68 | 6 | 12% | N/A | 30 d |
Melin et al[107], 2016 | 29 | 6.79 | 3 | 1 | Retrospective study |
- Citation: Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, Kerin M. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol 2019; 25(33): 4850-4869
- URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4850.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i33.4850